LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,122
تعداد مقالات10,284
تعداد مشاهده مقاله43,242,187
تعداد دریافت فایل اصل مقاله9,540,350
Sadri, Bahareh, Vosough, Massoud. (1403). Targeted immunotherapy approaches for intraductal papillary neoplasm of the bile duct. سامانه مدیریت نشریات علمی, 12(2), 58-60. doi: 10.30476/acrr.2024.102421.1214
Bahareh Sadri; Massoud Vosough. "Targeted immunotherapy approaches for intraductal papillary neoplasm of the bile duct". سامانه مدیریت نشریات علمی, 12, 2, 1403, 58-60. doi: 10.30476/acrr.2024.102421.1214
Sadri, Bahareh, Vosough, Massoud. (1403). 'Targeted immunotherapy approaches for intraductal papillary neoplasm of the bile duct', سامانه مدیریت نشریات علمی, 12(2), pp. 58-60. doi: 10.30476/acrr.2024.102421.1214
Sadri, Bahareh, Vosough, Massoud. Targeted immunotherapy approaches for intraductal papillary neoplasm of the bile duct. سامانه مدیریت نشریات علمی, 1403; 12(2): 58-60. doi: 10.30476/acrr.2024.102421.1214

Targeted immunotherapy approaches for intraductal papillary neoplasm of the bile duct

Iranian Journal of Colorectal Research
مقاله 4، دوره 12، شماره 2، شهریور 2024، صفحه 58-60    اصل مقاله (494.55 K)
نوع مقاله: Editorial
شناسه دیجیتال (DOI): 10.30476/acrr.2024.102421.1214
نویسندگان
Bahareh Sadri1؛ Massoud Vosough* 2
1Department of Regenerative Medicine, Cell Science Research Center, Royan institute for stem cell biology and technology, ACECR, Tehran, Iran.
2Department of Regenerative Medicine, Cell Science Research Center, Royan institute for stem cell biology and technology, Tehran, Iran
چکیده
Abstract: Intraductal papillary neoplasm of the bile duct (IPNB) is a complex biliary tract
neoplasm. Its classifications based on distinct clinical, pathological, and
radiological features and gene mutations, are of paramount importance. The
classification of IPNB into Type 1 and Type 2 has proven essential, as these
subtypes present notably different molecular alterations and clinical behaviors.
Type 1 IPNBs are characterized by KRAS, GNAS and RNF43 mutations. While,
Type 2 IPNBs demonstrate TP53, SMAD4, and KMT2C mutations. Recognition of
the subclasses along with the genetic alterations enables early detection and
advancement of personalized therapeutic methods. In addition, the identification of
more involved signaling pathways and their crosstalk are indispensable for the
advancement of novel therapeutic approaches including targeted immunotherapy
and gene therapy. These tailored approaches hold the promise of improving patient
outcomes, minimizing side effects, and offering a brighter future for those afflicted
by this intricate biliary neoplasm.The precise classification of IPNB besides the accurate identification of mutations and molecular alteration in each subclassification lead to the development of more accurate and efficient diagnostic and therapeutic methods.
کلیدواژه‌ها
Cholangiocarcinoma؛ Bile duct neoplasm؛ Papilloma؛ Intraductal
آمار
تعداد مشاهده مقاله: 45
تعداد دریافت فایل اصل مقاله: 76


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب